A comparative cross-sectional study conducted at the University of Ilorin Teaching Hospital in North-Central Nigeria has revealed that newborn umbilical-cord vitamin D concentrations trail maternal blood concentrations at delivery by a statistically significant margin. Investigating ninety-two healthy mother-neonate pairs, researchers observed that maternal concentrations averaged 28.54 nanograms per millilitre while paired neonatal cord-blood levels averaged 24.85 nanograms per millilitre. Although severe clinical deficiency was uncommon across both cohorts, more than sixty-five percent of the newborn infants exhibited serum concentrations falling into the insufficient range, demonstrating that maternal vitamin adequacy does not reliably ensure sufficiency in the neonate at birth.
Vitamin D functions as a pleiotropic hormone that supports placental calcium transport, modulates maternal immune responses, and directly influences fetal skeletal development. During pregnancy, circulating maternal 25-hydroxyvitamin D travels bound to vitamin-D-binding protein before entering the placenta via trophoblastic receptors. Within placental tissue, the precursor molecule can undergo local enzymatic activation by CYP27B1 into 1,25-dihydroxyvitamin D or enzymatic catabolism by CYP24A1. A regulated portion of maternal 25-hydroxyvitamin D crosses the syncytiotrophoblast barrier into the fetal circulation to support skeletal mineralisation, immune maturation, and systemic calcium homeostasis. Because the fetus relies entirely on placental transfer from the maternal circulation, neonatal levels at delivery closely mirror maternal stores but systematically fall short of equal concentration.
The study sought to measure both the absolute and relative maternal-neonatal gradient in an equatorial African setting characterised by abundant year-round sunlight. Previous epidemiological literature had documented that maternal 25-hydroxyvitamin D concentrations below 50 nanomoles per litre double the odds of pre-eclampsia and gestational diabetes while elevating risks for preterm birth and low birthweight. Prior investigations in Lagos, southern Nigeria, recorded maternal deficiency rates of 4.8 percent alongside neonatal deficiency rates of 29.5 percent, whereas cohorts in Johannesburg, South Africa, identified cord-blood values representing approximately eighty percent of maternal values. Understanding whether similar gradients persist in North-Central Nigeria provides empirical data for antenatal supplementation policies.
To establish the cohort, investigators enrolled pregnant women presenting for delivery at the University of Ilorin Teaching Hospital, situated at 8.3 degrees North latitude. The protocol applied stratified sampling with optimum allocation based on monthly labor suite delivery volumes to recruit participants. The research team excluded women with multiple gestations, preexisting chronic kidney or liver disease, endocrinopathies disturbing calcium metabolism, current high-dose vitamin D supplementation exceeding 1000 international units daily, or concurrent use of medications that alter vitamin D metabolism such as anticonvulsants, chemotherapy, or antituberculosis agents.
Sample collection occurred under strict aseptic conditions immediately upon delivery, obtaining two millilitres of maternal venous blood from the antecubital vein upon admission and two millilitres of cord venous blood from the clamped umbilical stump immediately following birth. Collected blood specimens were centrifuged at 2000 revolutions per minute for five minutes to isolate plasma, which was aliquoted and stored at minus twenty degrees Celsius until batch analysis. Total 25-hydroxyvitamin D concentrations, covering both 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 fractions, were quantified using a Calbiotech sandwich enzyme-linked immunosorbent assay calibrated against Bio-Rad trilevel controls. The assay possessed an analytical sensitivity of 2.0 nanograms per millilitre, with intra-assay and inter-assay coefficients of variation established at 6.4 percent and 8.1 percent, respectively.
Serum concentrations were categorized according to clinical thresholds established by the Endocrine Society, defining deficiency as values strictly below 20 nanograms per millilitre, insufficiency as concentrations from 20 to 29 nanograms per millilitre, and sufficiency as concentrations equal to or exceeding 30 nanograms per millilitre. The absolute gradient was calculated by subtracting neonatal cord concentrations from paired maternal concentrations, where positive values denote maternal excess. Across the ninety-two pairs, severe deficiency was identified in exactly 2.2 percent of mothers and 2.2 percent of neonates. However, 52.2 percent of mothers and 65.2 percent of newborns were classified as insufficient, while 45.7 percent of mothers and only 32.6 percent of neonates reached full sufficiency. Paired categorical shifts examined using McNemar chi-square testing showed a statistically significant discordance (chi-square = 8.97, p = 0.003), demonstrating that sufficient mothers frequently delivered insufficient infants.
Statistical evaluation using paired-samples t-tests confirmed that maternal concentrations significantly exceeded cord concentrations (t = 2.46, p = 0.015, 95% confidence interval 1.0 to 6.4 nanograms per millilitre). Maternal median concentrations stood at 28.89 nanograms per millilitre compared with a neonatal median of 24.00 nanograms per millilitre. Cord blood measurements exhibited wider variability and a lower absolute minimum, spanning from 5.0 to 55.0 nanograms per millilitre, compared to the maternal range of 21.8 to 76.3 nanograms per millilitre. Bivariate correlation analysis demonstrated a moderate, statistically significant positive linear relationship between paired maternal and cord-blood concentrations (Pearson r = 0.498, p < 0.001), corroborating global meta-analytic estimates showing that fetal stores correspond directly to maternal availability while consistently exhibiting a ten to thirty percent shortfall.
Subgroup comparisons across gestational age brackets revealed unexpected physiological variations, although overall group differences did not reach formal statistical significance (one-way ANOVA F = 1.69, p = 0.19). Neonates delivered early preterm between twenty-eight and thirty-two weeks exhibited the highest mean cord-blood concentration at 29.33 nanograms per millilitre. Term infants delivered between thirty-seven and forty-two weeks averaged 24.35 nanograms per millilitre, whereas late preterm infants delivered between thirty-two and thirty-seven weeks averaged 23.47 nanograms per millilitre. The authors noted that higher early concentrations might reflect preferential early placental transport, reduced haemodilution before late-pregnancy fetal plasma volume expansion, or slower metabolic utilization prior to rapid third-trimester fetal skeletal growth.
Biological mechanisms driving the transplacental gradient involve endocytic uptake mediated by megalin and cubilin receptors alongside local enzymatic processing. Ex-vivo placental perfusion studies indicate that human placental tissue actively metabolizes 25-hydroxyvitamin D into inactive metabolites via upregulated CYP24A1 expression, curtailing the net proportion transferred directly to the fetus. In dark-skinned populations residing in tropical environments, high epidermal melanin concentrations combined with modest direct cutaneous sunlight exposure and cultural clothing coverage attenuate cutaneous synthesis. Mathematical modeling based on the observed eighteen percent transplacental concentration drop suggests that maternal circulating concentrations may need to reach or exceed 36 nanograms per millilitre to secure neonatal cord concentrations above the 30 nanograms per millilitre sufficiency benchmark.
The authors outlined specific methodological strengths and limitations inherent to their study design. Standardised blood collection and uniform laboratory processing with blinded duplicate testing minimised analytical error across seasonal shifts. Furthermore, dietary intake and supplement use were self-reported rather than biochemically validated, and circulating free 25-hydroxyvitamin D and vitamin-D-binding protein levels were not directly quantified. The researchers concluded that high neonatal insufficiency rates justify re-evaluating universal antenatal supplementation guidelines in tropical, high-melanin populations rather than relying on assumed sunlight sufficiency.
Subject of Research: Maternal-neonatal vitamin D concentration gradient at birth in North-Central Nigeria
Article Title: Maternal–neonatal vitamin D gradient at birth in Ilorin, Nigeria: a comparative cross-sectional study
Article References: Ayodeji, O., Ayodele, O., Omotayo, A., Ariyibi, S., Sikiru, B., Popoola, G., Ayobola, A., Osonuga, A., Adebayo, U. O., Oso, T. A., Ayelaagbe, O. B., Agboola, A. A., & Lucero-Prisno III, D. E. (2026). Maternal–neonatal vitamin D gradient at birth in Ilorin, Nigeria: a comparative cross-sectional study. Maternal Health, Neonatology and Perinatology, 12(1), Article 24. https://doi.org/10.1186/s40748-026-00271-w
Image Credits: AI Generated
DOI: 10.1186/s40748-026-00271-w
Keywords: Vitamin D, 25-hydroxyvitamin D, Maternal health, Neonatal health, Cord blood, Placental transfer, Pregnancy, Ilorin, Nigeria, Sub-Saharan Africa, Cross-sectional study, Enzyme-linked immunosorbent assay, Gestational age, Endocrine Society, Antenatal supplementation, Endocrinology
News Source: Harold Sullivan. (November 21, 2026). Nigerian Study Finds Newborn Vitamin D Levels Systematically Trail Maternal Concentrations. Scienmag.



